Atlas Trials

Trevi Therapeutics

16 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Trevi Therapeutics

RecordFirmDate
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets (NCT07671911)Trevi Therapeutics2026-06-29
The Effect of Nalbuphine Extended-Release (NAL ER) on Cough in Participants With Refractory Chronic Cough (RCC) (NCT07671924)Trevi Therapeutics2026-06-22
A Food Effect Study to Evaluate the Relative Bioavailability of Nalbuphine Extended-Release Tablets (NAL ER) in Healthy Participants (NCT07487740)Trevi Therapeutics2026-02-27
NAL ER IPF Respiratory Function and Safety Study (NCT07036029)Trevi Therapeutics2025-08-21
Cough Reduction in IPF With Nalbuphine ER (NCT05964335)Trevi Therapeutics2024-02-06
Refractory Chronic Cough Improvement Via NAL ER (RIVER) (NCT05962151)Trevi Therapeutics2023-11-30
A Study of Nalbuphine (Extended Release) ER in Idiopathic Pulmonary Fibrosis (IPF) for Treatment of Cough (NCT04030026)Trevi Therapeutics2019-10-29
Study of Nalbuphine ER in Participants With Hepatic Impairment (NCT04020016)Trevi Therapeutics2019-06-12
PRISM Study-Pruritus Relief Through Itch Scratch Modulation (NCT03497975)Trevi Therapeutics2018-08-07
Oral Abuse Potential Study of Nalbuphine (NCT04018664)Trevi Therapeutics2018-05-29

Track Trevi Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.